October 29, 2012
Franciscan Patients Not Affected By Multi-State Meningitis Outbreak
Franciscan Health System has not used the medication produced by the compounding pharmacy, New England Compounding Center (NECC), which the U.S. Centers for Disease Control has identified as the likely source for the multi-state outbreak of Aspergillus meningitis associated with epidural steroid injections.
As a precaution, the federal Food and Drug Administration announced a recall Oct. 6 of all NECC products supplied to hospitals and health systems across the nation. Franciscan immediately stopped using the only medication (Sulphan Blue 1%) it had ever purchased from NECC.
Franciscan representatives also contacted by phone and letter all 25 patients who had received the medication. The individuals were 1) assured that no infection had been identified from the use of the medication and 2) provided a point of contact at Franciscan if they should experience specific symptoms or have additional questions.
High-quality care and patient safety are the highest priorities for the Franciscan Health System.